The stock wizards at Edelweiss deserve to be complimented for their brilliant stock selection. From 4th June 2014 onwards, the Midcap Marvels Model Portfolio has outperformed the benchmark CNX Midcap Index by a whopping 50%.
Edelweiss explains that the stocks chosen by them are high conviction mid-cap and small-cap stocks which are relatively strong on the fundamental side, with potential for exponential revenue growth, high ROCE, strong margins and credible corporate governance.
Edelweiss adds that the stocks are intended to be held with an investment horizon of 1-2 years.
|S. No.||Stock Name||Reco Price (Rs)||CMP (2nd Mar 2015) (Rs)||Returns (%)|
|1||Can Fin Homes Ltd (ex rights)||367||625||70%|
|3||Mayur Uniquoters Ltd||354||460||30%|
|4||Natco Pharma Ltd||744||1428||92%|
|5||Ratnamani Metals & Tubes Ltd||374||739||97%|
|6||Suprajit Engineering Ltd*||136||135||0%|
|7||Indo Count Industries||441||395||-10%|
Except for one stock (Indo Count) all the other stocks have given bumper gains. Ratnamani Metals and Natco Pharma have given gains in excess of 90%. Can Fin Homes and Cholamandalam have given gains in excess of 60%.
Wabco India Ltd has given gains of 101% and is being replaced by Suprajit Engineering.
There is a detailed rationale given for selecting each stock which is worth reading for its clarity.